UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: +1 |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
|||
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 7, 2022, Surrozen, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders ("Annual Meeting"). A total of 35,125,886 shares of the Company's common stock were entitled to vote as of April 11, 2022, the record date for the Annual Meeting, of which 22,468,813 shares were represented in person or by proxy at the Annual Meeting.
At the Annual Meeting, the shareholders of the Company voted on the following proposals:
The results of each of the above proposals are discussed further below.
Proposal 1 - Election of Directors
The votes cast for or withheld for each director nominee were as follows:
Director Nominee |
For |
Against |
Abstain |
Broker Non-Votes |
Tim Kutzkey, Ph.D. |
20,514,695 |
0 |
903,142 |
1,050,976 |
Anna Berkenblit, M.D. |
20,514,693 |
0 |
903,144 |
1,050,976 |
Accordingly, both of the nominees listed above was elected to serve as a director of the Company until the 2025 Annual Meeting of Shareholders and until his or her successor is duly elected and qualified.
Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm
The voting results with respect to the proposal to ratify the appointment of Ernst & Young LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 were as follows:
For |
Against |
Abstain |
22,467,087 |
1,702 |
24 |
Accordingly, the Company’s shareholders ratified the appointment of Ernst & Young LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
No other matters were submitted to a vote of shareholders at the Annual Meeting.
Item 9.01 Financial Statements and Exhibits.
(d) |
Exhibits |
|
|
|
Exhibit |
|
Description |
104 |
|
Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
SURROZEN, INC. |
|
|
|
|
Date: |
June 14, 2022 |
By: |
/s/ Sheela Mohan-Peterson |
|
|
|
Name: Sheela Mohan-Peterson |